negative side effects of semaglutide Effects: What Patients Should Know in 2025 FDA alerts health care providers,
Description
Mounjaro is the first and only approved once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist
The under-eyes sink, producing a chronically tired look that does not resolve with sleep or concealer
But multiple dental office websites do mention dry mouth as a side effect of GLP-1 agonist use
doi: 10.1016/S0079-6123(07)00006-4
Global experts like Dr
In theory, this pharmacological profile might allow orforglipron to maintain its effectiveness longer than traditional full GLP-1 receptor agonists
